Konu "Efficacy" için WoS İndeksli Yayınlar Koleksiyonu listeleme
Toplam kayıt 6, listelenen: 1-6
-
Effect of fulvic acid on gastric mucosa damage caused by chronic water avoidance stress
(Taylor & Francis Ltd, 2021)We investigated the antioxidant and anti-ulcerogenic effects of fulvic acid (FA) on oxidative damage caused by water avoidance stress (WAS) in rat gastrointestinal mucosa. Three experimental groups were established: control ... -
Effectiveness of the mulligan mobilization technique in mechanical neck pain
(DERMAN MEDICAL PUBL, 2018)Aim: The aim of this study was to investigate the effectiveness of Mulligan Mobilization technique in participants with mechanical neck pain. Material and Method: A total of 40 participants (35 female, 5 male) aged between ... -
Investigation of DPYD, MTHFR and TYMS polymorphisms on 5-fluorouracil related toxicities in colorectal cancer
(Future Medicine Ltd, 2022)Aim: To investigate the association of DPYD, MTHFR and TYMS polymorphisms on 5-fluorouracil (5-FU) related toxicities and patient survival. Materials & methods: A total of 103 colorectal cancer patients prescribed 5-FU ... -
Modified DCF (mDCF) regimen seems to be as effective as original DCF in advanced gastric cancer (AGC)
(SPRINGER, 2013)The aim of this retrospective study (from January 2007 to December 2011) was to investigate the efficacy and tolerability of mDCF schedule for chemotherapy-na < ve AGC patients. Patients (n = 54) with locally inoperable ... -
A real-life analysis of patients with rheumatologic diseases on biological treatments: Data from TURKBIO Registry
(Aves, 2022)Objective: TURKBIO registry, established in 2011, is the first nationwide biological database in Turkey. This study aimed to provide an overview of TURKBIO data collected by June 2018. Methods: The registry included adult ... -
Use of follow-on fingolimod for multiple sclerosis: Analysis of effectiveness and patient reported outcomes in a real-world clinical setting
(Elsevier Sci Ltd, 2023)Background: Follow-on disease modifying therapies (FO-DMTs) do not always require Phase III studies. There are concerns that cheaper FO-DMTs are only used to reduce healthcare costs. However, the well-being of people with ...